Follow us on Twitter! See the latest updates from our team and across the medical community. @SSTLMC Twitter @SSTLMC


Latest updates from your local medical community

16th April 2024

General practice vaccination and immunisation services: standards and core contractual requirements

Since April 2021 the provision of all NHS-funded routine vaccination and immunisation (V&I) services for children and adults has been an essential service, except for the COVID-19, childhood and seasonal influenza (adults and at risk) vaccination programmes which continue to be commissioned as enhanced services.

7th April 2024

GP Contract 24/25

NHSE have published the latest reiteration of the GP contract for 2024/25. 

The full details can be accessed via the below link. 

5th April 2024

Members have overwhelmingly voted to reject the Government and NHS England’s 2024/25 GP contract changes

GPs across England have overwhelmingly voted to reject the announced Department of Health and Social Care and NHS England changes to the 2024/25 national GP General Medical Services (GMS) contract. 

More than 19,000 GPs and GP registrars took part in the BMA’s referendum, with 99.2% voting ‘no’ to the question: Do you accept the 2024/25 GMS Contract for General Practice from Government and NHS England?

13th March 2024

HRT guidance updates

An updated HRT PPC guidance document has been published by DHSC. 

13th March 2024

Preparing for the Spring 2024 COVID-19 vaccination campaign

Preparations are underway for the Spring 2024 COVID-19 vaccination campaign, following the achievements of the 2023 Autumn campaigns. 

Follow Us on X (formerly Twitter) Twitter @SSTLMC

Receive the latest updates from us and in real time on X (formerly Twitter) @SSTLMC. Retweets for interest; not necessarily endorsement.

Opening Hours

The LMC office is open Monday to Thursday 9am to 5pm. We endeavour to respond to all enquiries within 5 working days. In the first instance, please use our Contact Us page.   

You can also visit our CV19 page for the latest CV19 guidance.